Sickle Cell Disease & Thalassemia
1 clinical trials · Condition
◉ Watch Sickle Cell Disease & Thalassemia
| Record | Firm | Date |
|---|---|---|
| Allogeneic SCT of NiCord®, UCB-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients With Hemoglobinopathies (NCT01590628) | Gamida Cell ltd | 2012-09-01 |
Track Sickle Cell Disease & Thalassemia automatically
Every clearance here is in the API, with alerts when new ones post.